Treatment of recurrent HCV infection following liver transplantation: Results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirin-Reference-Cited by-同舟云学术

Treatment of recurrent HCV infection following liver transplantation: Results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirin

Published:2012-09 Issue:3 Volume:57 Page:564-571
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Calmus Yvon,Duvoux Christophe,Pageaux Georges,Wolf Philippe,Rostaing Lionel,Vanlemmens Claire,Botta-Fridlund Danielle,Dharancy Sébastien,Gugenheim Jean,Durand François,Néau-Cransac Martine,Boillot Olivier,Chazouillères Olivier,Samelson Laurence,Boudjema Karim,Samuel Didier

Publisher

Elsevier BV

Subject

Hepatology

Reference31 articles.

1. The association between hepatitis C infection and survival after orthotopic liver transplantation;Forman;Gastroenterology,2002

2. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients;Berenguer;Hepatology,2002

3. Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up;Neumann;Transplantation,2004

4. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group;Feray;Gastroenterology,1999

5. One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection;Firpi;Liver Transpl,2004

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expanding the liver donor pool worldwide with hepatitis C infected livers, is it the time?;World Journal of Transplantation;2024-06-18

2. Reply;Hepatology;2020-08

3. Fibrosing cholestatic hepatitis after kidney transplantation from HCV ‐viremic donors to HCV ‐negative recipients: A unique complication in the DAA era;American Journal of Transplantation;2019-09-18

4. Utilization and efficacy of elbasvir/grazoprevir for treating hepatitis C virus infection after liver transplantation;Hepatology Research;2018-07-19

5. A Closing Chapter: Hepatitis C Genotype 3 Elimination in Liver Transplant; Sofosbuvir/Daclatasvir in a Hard-to-Treat Population;Experimental and Clinical Transplantation;2018-02